RemeGen Biosciences Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
RemeGen Biosciences is a biopharmaceutical company focused on discovering and developing medicines to treat cancer and autoimmune diseases. It operates from South San Francisco, California, and Rockville, Maryland, and is a wholly owned subsidiary of RemeGen Co., a global pharmaceutical group that concentrates on autoimmune, oncology, and ophthalmic diseases. The organization seeks to identify novel therapeutic targets and advance biotherapeutics that could address significant unmet medical needs in patients. In the biotechnology research sector, the company draws on its understanding of cancer biology and immunology along with clinical development expertise to move candidates toward clinical testing. Its mandate centers on translating scientific insights into therapies for conditions that lack adequate treatments, aiming to deliver meaningful options for patients.